Fadzai Chinyengetere, Ph.D.
Affiliations: | 2013 | Pharmacology and Toxicology | Dartmouth College, Hanover, NH, United States |
Area:
Medicine and Surgery, Oncology, GeneralGoogle:
"Fadzai Chinyengetere"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ethan Dmitrovsky | grad student | 2013 | Dartmouth | |
| (Investigation of the ISG15 deisgylase UBP43 in carcinogenesis: Tumor suppressor or oncogene?) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mustachio LM, Lu Y, Tafe LJ, et al. (2017) Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer. Molecular Cancer Research : McR |
| Mustachio LM, Lu Y, Tafe LJ, et al. (2016) Abstract 1255: Loss of the ubiquitin protease USP18 represses KRAS mutant lung cancer tumorigenicity in mice by destabilizing KRAS protein Cancer Research. 76: 1255-1255 |
| Chinyengetere F, Sekula DJ, Lu Y, et al. (2015) Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas. Bmc Cancer. 15: 886 |
| Mustachio LM, Chinyengetere F, Lu Y, et al. (2014) Abstract 1782: The ubiquitin protease UBP43 is a target for KRAS mutant lung cancers Cancer Research. 74: 1782-1782 |
| Ma T, Galimberti F, Erkmen CP, et al. (2013) Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Molecular Cancer Therapeutics. 12: 1545-55 |
| Lu Y, Mustachio LM, Chinyengetere F, et al. (2013) Abstract 4125: The retinoid-induced G0S2 protein undergoes ISG15ylation and destabilization. Cancer Research. 73: 4125-4125 |
| Chinyengetere F, Giustini A, Sekula D, et al. (2013) Abstract 1089: Spontaneous formation of sarcomas in Usp18 knockout mice. Cancer Research. 73: 1089-1089 |
| Galimberti F, Busch AM, Chinyengetere F, et al. (2012) Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations. International Journal of Oncology. 41: 1751-61 |
| Guo Y, Chinyengetere F, Dolinko AV, et al. (2012) Evidence for the ubiquitin protease UBP43 as an antineoplastic target. Molecular Cancer Therapeutics. 11: 1968-77 |
| Guo Y, Chinyengetere F, Dolinko AV, et al. (2011) Abstract 1655: The ubiquitin protease UBP43 is a target for lung cancer therapy and prevention Cancer Research. 71: 1655-1655 |